Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4584732
Max Phase: Preclinical
Molecular Formula: C42H58F6N4O12S2
Molecular Weight: 875.04
Molecule Type: Unknown
Associated Items:
ID: ALA4584732
Max Phase: Preclinical
Molecular Formula: C42H58F6N4O12S2
Molecular Weight: 875.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N[C@@H](CC(=O)NC1(c2nc3ccc(OCCCCCCCCCCCC(=O)NC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO)cc3s2)CCS(=O)(=O)CC1)Cc1cc(F)c(F)cc1F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C40H57F3N4O10S2.C2HF3O2/c41-28-22-30(43)29(42)19-25(28)18-26(44)20-36(52)47-40(13-16-59(55,56)17-14-40)39-46-31-12-11-27(21-34(31)58-39)57-15-9-7-5-3-1-2-4-6-8-10-35(51)45-23-32(49)37(53)38(54)33(50)24-48;3-2(4,5)1(6)7/h11-12,19,21-22,26,32-33,37-38,48-50,53-54H,1-10,13-18,20,23-24,44H2,(H,45,51)(H,47,52);(H,6,7)/t26-,32+,33-,37-,38+;/m1./s1
Standard InChI Key: LAKAHZATDDNMLP-YWVZQWNWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 875.04 | Molecular Weight (Monoisotopic): 874.3468 | AlogP: 3.03 | #Rotatable Bonds: 25 |
Polar Surface Area: 241.63 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.55 | CX Basic pKa: 8.38 | CX LogP: 1.62 | CX LogD: 0.60 |
Aromatic Rings: 3 | Heavy Atoms: 59 | QED Weighted: 0.05 | Np Likeness Score: -0.49 |
1. Huang F, Ning M, Wang K, Liu J, Guan W, Leng Y, Shen J.. (2019) Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors., 62 (23): [PMID:31747282] [10.1021/acs.jmedchem.9b01649] |
Source(1):